Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04721418

Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C-UCB-J PET Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
Yale University · Academic / Other
Sex
All
Age
21 Years – 60 Years
Healthy volunteers
Accepted

Summary

The purpose of this research study is to measure synaptic density in the brain comparing individuals with cocaine use disorder to healthy controls.

Detailed description

Healthy controls (HC) will be studied as outpatients and undergo one MRI and one 11C-UCB-J PET scan, along with neurocognitive tasks. Individuals with Cocaine Use Disorder (CUD) will complete the study as inpatients on our unit and undergo one MRI and two 11C-UCB-J PET scans, along with neurocognitive tasks. Participants will complete sleep studies (to evaluate sleep architecture); the first two nights after admission and the last two nights before discharge. Cocaine users will be asked to complete outpatient follow-ups twice a week for up to nine weeks following their inpatient stay.

Conditions

Interventions

TypeNameDescription
RADIATION11C-UCB-J11C-UCB-J PET scan

Timeline

Start date
2021-07-20
Primary completion
2026-06-01
Completion
2026-06-01
First posted
2021-01-22
Last updated
2025-09-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04721418. Inclusion in this directory is not an endorsement.

Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C-UCB-J PET Study (NCT04721418) · Clinical Trials Directory